Hikal Limited
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, wh… Read more
Hikal Limited (HIKAL) - Total Liabilities
Latest total liabilities as of September 2025: ₹11.55 Billion INR
Based on the latest financial reports, Hikal Limited (HIKAL) has total liabilities worth ₹11.55 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Hikal Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how Hikal Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Hikal Limited Competitors by Total Liabilities
The table below lists competitors of Hikal Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
JUKCF
PINK:JUKCF
|
USA | $97.26 Billion |
|
Sao Ta Foods JSC
VN:FMC
|
Vietnam | ₫2.22 Trillion |
|
ISU Abxis Co. Ltd
KQ:086890
|
Korea | ₩45.29 Billion |
|
Bancorp. of Southern Indiana
PINK:BCSO
|
USA | $908.91 Million |
|
HYUNDAI FEED Inc
KQ:016790
|
Korea | ₩28.17 Billion |
|
Intai Technology
TWO:4163
|
Taiwan | NT$2.12 Billion |
|
Koenig & Bauer AG
XETRA:SKB
|
Germany | €1.11 Billion |
|
Summit State Bank
NASDAQ:SSBI
|
USA | $903.41 Million |
Liability Composition Analysis (2005–2025)
This chart breaks down Hikal Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.03 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.97 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hikal Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hikal Limited (2005–2025)
The table below shows the annual total liabilities of Hikal Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹12.67 Billion | -2.53% |
| 2024-03-31 | ₹12.99 Billion | +3.79% |
| 2023-03-31 | ₹12.52 Billion | +9.33% |
| 2022-03-31 | ₹11.45 Billion | +16.87% |
| 2021-03-31 | ₹9.80 Billion | +2.98% |
| 2020-03-31 | ₹9.51 Billion | +2.39% |
| 2019-03-31 | ₹9.29 Billion | +6.53% |
| 2018-03-31 | ₹8.72 Billion | +12.63% |
| 2017-03-31 | ₹7.74 Billion | +8.89% |
| 2016-03-31 | ₹7.11 Billion | -6.36% |
| 2015-03-31 | ₹7.60 Billion | -0.71% |
| 2014-03-31 | ₹7.65 Billion | +3.26% |
| 2013-03-31 | ₹7.41 Billion | +5.66% |
| 2012-03-31 | ₹7.01 Billion | +5.63% |
| 2011-03-31 | ₹6.64 Billion | -0.24% |
| 2010-03-31 | ₹6.65 Billion | -9.20% |
| 2009-03-31 | ₹7.33 Billion | +23.36% |
| 2008-03-31 | ₹5.94 Billion | +43.51% |
| 2007-03-31 | ₹4.14 Billion | +7.62% |
| 2006-03-31 | ₹3.85 Billion | +25.08% |
| 2005-03-31 | ₹3.07 Billion | -- |